By the numbers
0.0M
Medical communitymembers
0K
Curated contentpieces
0M+
Monthlypageviews
By the numbers
0.0M
Medical communitymembers
0K
Curated contentpieces
0M+
Monthlypageviews
TribeMD
Eventos
Notícias em alta
CardiologyApr 3, 2026
10 min read
ACC 2026 – DKCRUSH VIII: IVUS or Angiography Guidance for Percutaneous Coronary Intervention in Complex Coronary Bifurcation Lesions
Dr. Michael Gibson* and Dr. Shao Liang Chen**, discuss the main findings of the DKCRUSH VIII trial in the context of complex coronary bifurcation lesions.*CEO of the non-profit Baim / PERFUSE Research Institute; Harvard Professor; Cardiologist at BIDMC; Founder and President of WikiDoc.org.** Investigator in the DKCRUSH VIII trial; Interventional cardiologist in Nanjing First Hospital, Nanjing Medical UniversityThe DKCRUSH VIII study evalu
ACC 2026Apr 1, 2026
8 min read
ACC 2026 – SMART-DECISION: Beta-blocker discontinuation after myocardial infarction does not increase events in stable patients
The SMART-DECISION trial evaluated stable post–myocardial infarction patients without heart failure and with a left ventricular ejection fraction ≥40%, demonstrating that beta-blocker discontinuation after 1 year was noninferior to continuation regarding death, reinfarction, or hospitalization for heart failure.The SMART-DECISION trial investigated whether discontinuing beta-blocker therapy could be a safe strategy in clinically stable patients following myocardial
ACC 2026Apr 1, 2026
10 min read
ACC 2026 – IVUS-CHIP: Intravascular ultrasound-guided or angiography-guided complex high-risk PCI.
Dr. Michael Gibson* and Dr. Roberto Diletti**, discuss the main findings of the IVUS-CHIP study in the context of percutaneous coronary intervention in high-complexity patients.*CEO of the non-profit Baim / PERFUSE Research Institute; Harvard Professor; Cardiologist at BIDMC; Founder and President of WikiDoc.org.** Investigator in the IVUS-CHIP trial; Interventional cardiologist at the Thoraxcenter, Erasmus MC, in RotterdamIVUS-CHIP was a
ACC 2026Mar 31, 2026
10 min read
ACC 2026 – PRO-TAVI: Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
Dr. Michael Gibson* and Dr. Ronak Delewi**, discuss the main findings of the PRO-TAVI study in patients undergoing transcatheter aortic valve implantation.*CEO of the non-profit Baim / PERFUSE Research Institute; Harvard Professor; Cardiologist at BIDMC; Founder and President of WikiDoc.org.** Investigator in the PRO-TAVI study; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of AmsterdamThe PRO-TAVI
